Metabolism-Directed Design of Oxetane-Containing Arylsulfonamide Derivatives as γ-Secretase InhibitorsAntonia F. Stepan, R. Scott Obach, Jason K. Dutra et al.|Journal of Medicinal Chemistry|2011Cited by 106
P3‐053: Existing data support wild‐type mouse is a suitable preclinical model for predicting human CSF abeta efficacy of gamma secreatase inhibitorsLiming Zhang, Jennifer L. Liras, Yasong Lu et al.|Alzheimer s & Dementia|2011Cited by 0